National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012

JAMA Pediatrics

Volumn 170, Issue 12, 2016, Pages 1195-1201

  Gaither, Julie R ^a,b   Leventhal, John M ^a   Ryan, Sheryl A ^a   Camenga, Deepa R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE; OPIATE; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; COCHRAN ARMITAGE TEST; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DRUG INTOXICATION; FEMALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; ICD-9; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREND STUDY; UNITED STATES; YOUNG ADULT; AGE DISTRIBUTION; DRUG OVERDOSE; HEROIN DEPENDENCE; INFANT; SELF-INJURIOUS BEHAVIOR; STATISTICS AND NUMERICAL DATA; SUICIDE; TRENDS;

ADOLESCENT; AGE DISTRIBUTION; ANALGESICS, OPIOID; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG OVERDOSE; FEMALE; HEROIN DEPENDENCE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE; METHADONE; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; SELF-INJURIOUS BEHAVIOR; SUICIDE; UNITED STATES; YOUNG ADULT;

EID: 85011419254     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2016.2154     Document Type: Article

References (52)

1. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief. 2009;(22):1-8.
2. Chen LH, Hedegaard H,Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS Data Brief. 2014; (166):1-8.
3. Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241-248.
4. Manchikanti L, Helm S II, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012; 15(3)(suppl):ES9-ES38.
5. Von KorffM, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med. 2011;155(5):325-328.
6. Von KorffM, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain [published correction appears in Clin J Pain. 2014;30(9):830]. Clin J Pain. 2008;24(6):521-527.
7. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013;131(3):263-270.
8. National Center for Health Statistics. Number and age-adjusted rates of drug-poisoning deaths involving opioid analgesics and heroin: United States 2000-2014. https://www.cdc.gov/nchs/data /health-policy/AADR-drug-poisoning-involving-OA-Heroin-US-2000-2014.pdf. Published 2014. Accessed May 31, 2016.
9. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355-362.
10. Morasco BJ, Turk DC, Donovan DM, Dobscha SK. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend. 2013;127(1-3):193-199.
11. Tetrault JM, Desai RA, BeckerWC, Fiellin DA, Concato J, Sullivan LE. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction. 2008;103(2):258-268.
12. Miech R, Johnston L, O'Malley PM, Keyes KM, Heard K. Prescription opioids in adolescence and future opioid misuse. Pediatrics. 2015;136(5): e1169-e1177.
13. Li L, Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk ofmyocardial infarction amongst adults. J Intern Med. 2013;273(5):511-526.
14. Saunders KW, Dunn KM, Merrill JO, et al. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med. 2010;25(4):310-315.
15. Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015;175(4): 608-615.
16. Edlund MJ, Forman-Hoffman VL, Winder CR, et al. Opioid abuse and depression in adolescents: results from the National Survey on Drug Use and Health. Drug Alcohol Depend. 2015;152:131-138.
17. Lovegrove MC, Mathew J, Hampp C, Governale L,Wysowski DK, Budnitz DS. Emergency hospitalizations for unsupervised prescription medication ingestions by young children. Pediatrics. 2014;134(4):e1009-e1016.
18. Lovegrove MC,Weidle NJ, Budnitz DS. Trends in emergency department visits for unsupervised pediatric medication exposures, 2004-2013. Pediatrics. 2015;136(4):e821-e829.
19. Bond GR,Woodward RW, HoM. The growing impact of pediatric pharmaceutical poisoning [published correction appears in J Pediatr. 2012;160(5):888-889]. J Pediatr. 2012;160(2): 265-270.e1.
20. Burghardt LC, Ayers JW, Brownstein JS, Bronstein AC, Ewald MB, Bourgeois FT. Adult prescription drug use and pediatric medication exposures and poisonings. Pediatrics. 2013;132(1): 18-27.
21. Centers for Disease Control and Prevention (CDC). Emergency department visits involving nonmedical use of selected prescription drugs: United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2010;59(23):705-709.
22. Bailey JE, Campagna E, Dart RC; RADARS System Poison Center Investigators. The underrecognized toll of prescription opioid abuse on young children. Ann Emerg Med. 2009;53(4): 419-424.
23. Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, Bossarte RM. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010;38(5):517-524.
24. Rubin R. Analysis reveals large increase in hospitalizations in recent years among older patients prescribed opioids. JAMA. 2014;312(16): 1621-1623.
25. Meiman J, Tomasallo C, Paulozzi L. Trends and characteristics of heroin overdoses in Wisconsin, 2003-2012. Drug Alcohol Depend. 2015;152:177-184.
26. Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. N Engl J Med. 2012;367(2):187-189.
27. Cicero TJ, Ellis MS. Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin. JAMA Psychiatry. 2015;72(5):424-430.
28. Pollini RA, Banta-Green CJ, Cuevas-Mota J, Metzner M, Teshale E, Garfein RS. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil. 2011;2(1):173-180.
29. Centers for Disease Control and Prevention. Vital signs: risk for overdose from methadone used for pain relief-United States, 1999-2010. Vital Signs Factsheet 2012. https://www.cdc.gov/mmwr /preview/mmwrhtml/mm6126a5.htm. Published July 6, 2012. Accessed June 7, 2016.
30. Centers for Disease Control and Prevention. Opioid painkiller prescribing. Vital Signs Factsheet. http://www.cdc.gov/vitalsigns/opioid-prescribing/. Updated July 1, 2014. Accessed November 18, 2015.
31. US Food and Drug Administration. CDER conversation: pediatric pain management options. http://www.fda.gov/Drugs/NewsEvents /ucm456973.htm. Updated August 14, 2015. Accessed November 17, 2015.
32. Healthcare Cost and Utilization Project. Introduction to the HCUP KIDS' Inpatient Database (KID). https://www.hcup-us.ahrq.gov. Modified September 20, 2016. Accessed June 7, 2016.
33. Agency for Healthcare Research and Quality. Care of children and adolescents in US hospitals. http://archive.ahrq.gov/data/hcup/factbk4/factbk4 .htm. Modified September 14, 2016. Accessed June 7, 2016.
34. World Health Organization. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Geneva, Switzerland:World Health Organization; 2010.
35. Centers for Disease Control and Prevention. WISQARS (Web-based Injury Statistics Query and Reporting System). http://www.cdc.gov/injury /wisqars/. Updated May 4, 2016. Accessed November 18, 2015.
36. Healthcare Cost and Utilization Project. HCUPnetmethodology. http://hcupnet.ahrq.gov /HCUPnet.jsp?GoTo=HCUPnetMethodology. Published 2014. Accessed May 12, 2016.
37. Healthcare Cost and Utilization Project. Calculating Kids' Inpatient Database (KID) variances. https://www.hcup-us.ahrq.gov/db /nation/kid/reports/CalculatingKIDVariances.pdf. Published December 16, 2005. Accessed November 19, 2015.
38. Centers for Disease Control and Prevention NCfHS. Bridged-race population estimates: 1990-2011 request. http://wonder.cdc.gov/bridged-race-v2011.html. Published 2015. Accessed November 19, 2015.
39. Base SAS. 9.2 Procedures Guide: Statistical Procedures, Third Edition. https://support.sas.com /documentation/cdl/en/statug/63033/HTML /default/viewer.htm#statug-freq-a0000000645 .htm. Updated May 19, 2010. Accessed September 20, 2016.
40. Curtin SC,Warner M, Hedegaard H. Increase in suicide in the United States, 1999-2014. NCHS Data Brief. 2016;(241):1-8.
41. Pfuntner A, Wier LM, Stocks C. Most Frequent Conditions in US Hospitals, 2011: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Healthcare Cost and Utilization Project; 2006. Statistical brief 62.
42. Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin-and opioid-related overdoses, 1993-2009. PLoS One. 2013;8(2):e54496.
43. Center for Behavioral Health Statistics and Quality. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health. Health and Human Services publication SMA 15-4927, NSDUH Series H-50. http: //www.samhsa.gov/data. Published 2015. Accessed March 29, 2016.
44. McCabe SE, Boyd CJ, Cranford JA, Teter CJ. Motives for nonmedical use of prescription opioids among high school seniors in the United States: self-treatment and beyond. Arch Pediatr Adolesc Med. 2009;163(8):739-744.
45. McCabe SE,West BT, Boyd CJ. Leftover prescription opioids and nonmedical use among high school seniors: a multi-cohort national study. J Adolesc Health. 2013;52(4):480-485.
46. Fortuna RJ, Robbins BW, Caiola E, Joynt M, Halterman JS. Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics. 2010;126(6):1108-1116.
47. DeVries A, Koch T,Wall E, Getchius T, ChiW, Rosenberg A. Opioid use among adolescent patients treated for headache. J Adolesc Health. 2014;55(1):128-133.
48. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. MMWR Recomm Rep. 2016;65(1):1-49.
49. Olsen Y. The CDC guideline on opioid prescribing: rising to the challenge. JAMA. 2016;315 (15):1577-1579.
50. Schechter NL,Walco GA. The potential impact on children of the CDC guideline for prescribing opioids for chronic pain: above all, do no harm. JAMA Pediatr. 2016;170(5):425-426.
51. de Achaval S, Feudtner C, Palla S, Suarez-Almazor ME. Validation of ICD-9-CM codes for identification of acetaminophen-related emergency department visits in a large pediatric hospital. BMC Health Serv Res. 2013;13:72.
52. Califf RM,Woodcock J, Ostroff S. A proactive response to prescription opioid abuse. N Engl J Med. 2016;374(15):1480-1485.